Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-005672
Filing Date
2019-04-02
Accepted
2019-04-02 20:28:32
Documents
1
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3972
  Complete submission text file 0001213900-19-005672.txt   5449
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 GVULOT ST. GIVATAYIM L3 5326111
Business Address
Zarzewsky Joseph (Reporting) CIK: 0001723700 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 19727235